Insider · CIK 0001821530
Edward J Dulac III
Files at NTLA (Intellia Therapeutics, Inc.). First filing Jul 25, 2025, latest Jul 25, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 32Weak | NTLAsell Intellia Therapeutics, Inc. | $105k 7,462 shares | -7% | +127% from low-38% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -7,462 | $14.02 | $105k | 106,062 | Jul 25, 2025 |
| Mar 1, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +47,200 | $0.00 | $0 | 113,524 | Mar 4, 2025 |
| Mar 1, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +67,429 | $0.00 | $0 | 67,429 | Mar 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.